COH:ASX
코클리어
AU$129.00
arrow_downward
-0.39%(-0.50) 1D
10월 8일, 오후 4시 10분 20초 GMT+11 · AUD
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoCOH의 주요 통계 생성 중...
시가
AU$129.16
고가
AU$130.96
저가
AU$127.83
시가총액
84.43억
평균 거래량
73.67만
거래량
29.76만
배당금
2.67%
분기 배당금
AU$0.86
배당락일
2026. 9. 21.
주가수익률
57.39
52주 최고가
AU$296.50
52주 최저가
AU$88.74
EPS
AU$2.25
유통 주식수
6539.89만
직원 수
5천
시가
AU$129.16
고가
AU$130.96
저가
AU$127.83
시가총액
84.43억
평균 거래량
73.67만
거래량
29.76만
배당금
2.67%
분기 배당금
AU$0.86
배당락일
2026. 9. 21.
주가수익률
57.39
52주 최고가
AU$296.50
52주 최저가
AU$88.74
EPS
AU$2.25
유통 주식수
6539.89만
직원 수
5천
뉴스 기사
웹 소스 및 뉴스 파트너 제공
AD HOC NEWS
·
7시간 전
Cochlear stock gets a Hold call as FY26 risks persist
Simply Wall Street
·
23시간 전
3 Australian Healthcare Stocks With Earnings Growth Over 22%
Investing.com
·
1일 전
Lake Street initiates Envoy Medical stock at buy on cochlear device
프로필
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
코클리어에 관한 정보